scholarly article | Q13442814 |
P2093 | author name string | Hossein Hosseinzadeh | |
Soghra Mehri | |||
Bibi Marjan Razavi | |||
Amir Foroutanfar | |||
Marzyeh Kamyar | |||
Faezeh Vahdati Hasani | |||
P2860 | cites work | Vitamin E for neuroleptic-induced tardive dyskinesia | Q24236633 |
Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice | Q24805490 | ||
Razi's Al-Hawi and saffron (Crocus sativus): a review | Q26766059 | ||
Saffron as an antidote or a protective agent against natural or chemical toxicities | Q27021426 | ||
Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents | Q28272906 | ||
Protective effects of carotenoids from saffron on neuronal injury in vitro and in vivo | Q28282662 | ||
Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents | Q28284395 | ||
Effects of crocin on reperfusion-induced oxidative/nitrative injury to cerebral microvessels after global cerebral ischemia | Q28286660 | ||
Anti-inflammatory effects of crocin and crocetin in rat brain microglial cells | Q28293743 | ||
Co-administration of progabide inhibits haloperidol-induced oral dyskinesias in rats | Q28319349 | ||
Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction | Q29616762 | ||
Crocin suppresses LPS-stimulated expression of inducible nitric oxide synthase by upregulation of heme oxygenase-1 via calcium/calmodulin-dependent protein kinase 4 | Q30413038 | ||
Bioactivity assessment and toxicity of crocin: a comprehensive review | Q30701307 | ||
Dopamine/adenosine interactions related to locomotion and tremor in animal models: possible relevance to parkinsonism | Q33591302 | ||
Pharmacokinetics of haloperidol: an update | Q33813315 | ||
Tardive dyskinesia: possible involvement of free radicals and treatment with vitamin E. | Q33833704 | ||
Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia? | Q33881866 | ||
Orofacial dyskinesia. Clinical features, mechanisms and drug therapy | Q34050289 | ||
Tardive dyskinesias and antipsychotics: a review | Q34132242 | ||
Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. | Q34204611 | ||
Glutamate neurotoxicity, oxidative stress and mitochondria. | Q34263800 | ||
Oxidative mechanisms and tardive dyskinesia | Q35017644 | ||
Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms | Q35044374 | ||
Involvement of brain-derived neurotrophic factor (BDNF) on malathion induced depressive-like behavior in subacute exposure and protective effects of crocin | Q36391871 | ||
Determination of oxidative stress and activities of antioxidant enzymes in guinea pigs treated with haloperidol. | Q36603481 | ||
An update on tardive dyskinesia: from phenomenology to treatment | Q37006021 | ||
Approaches to prevent dopamine quinone-induced neurotoxicity | Q37260391 | ||
Mitigation of obesity-promoted diseases by Nigella sativa and thymoquinone | Q38000175 | ||
Avicenna's (Ibn Sina) the Canon of Medicine and saffron (Crocus sativus): a review. | Q38027811 | ||
Tardive dyskinesia is caused by maladaptive synaptic plasticity: a hypothesis | Q38032249 | ||
Oxidative stress and tardive dyskinesia: pharmacogenetic evidence. | Q38057552 | ||
Haloperidol cytotoxicity and its relation to oxidative stress. | Q38155601 | ||
Oxidative stress and the antipsychotic-induced vacuous chewing movement model of tardive dyskinesia: evidence for antioxidant-based prevention strategies | Q38206130 | ||
Preventive effect of crocin in inflamed animals and in LPS-challenged RAW 264.7 cells | Q39799680 | ||
Antitumor effects of saffron-derived carotenoids in prostate cancer cell models | Q40029476 | ||
Protective effect of crocin on acrolein-induced tau phosphorylation in the rat brain. | Q40670746 | ||
Antidepressant effects of crocin and its effects on transcript and protein levels of CREB, BDNF, and VGF in rat hippocampus | Q41963020 | ||
Dietary Crocin Inhibits Colitis and Colitis-Associated Colorectal Carcinogenesis in Male ICR Mice | Q42277214 | ||
Acute administration of haloperidol induces apoptosis of neurones in the striatum and substantia nigra in the rat. | Q42515481 | ||
Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: role of dopamine transporter | Q42627801 | ||
Bauhinia forficata prevents vacuous chewing movements induced by haloperidol in rats and has antioxidant potential in vitro. | Q42685864 | ||
Influence of malathion on acetylcholinesterase activity in rats submitted to a forced swimming test | Q42688776 | ||
Extraction and purification of crocin from saffron stigmas employing a simple and efficient crystallization method | Q42727544 | ||
Crocin attenuates cisplatin-induced renal oxidative stress in rats | Q42988359 | ||
Age-dependent effects of a chronic ultramild stress procedure on open-field behaviour in B6D2F1 female mice | Q43340887 | ||
Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide | Q43695355 | ||
Possible involvement of prostaglandins in haloperidol-induced orofacial dyskinesia in rats | Q43800969 | ||
Crocin suppresses tumor necrosis factor-alpha-induced cell death of neuronally differentiated PC-12 cells | Q43807028 | ||
Possible mechanism of action in melatonin attenuation of haloperidol-induced orofacial dyskinesia | Q44288274 | ||
Vitamin E attenuates reserpine-induced oral dyskinesia and striatal oxidized glutathione/reduced glutathione ratio (GSSG/GSH) enhancement in rats. | Q44292648 | ||
Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia | Q44451135 | ||
Effects of valproic acid on an animal model of tardive dyskinesia. | Q44472615 | ||
Effect of Withania somnifera root extract on haloperidol-induced orofacial dyskinesia: possible mechanisms of action | Q44560118 | ||
Determination of malonaldehyde precursor in tissues by thiobarbituric acid test | Q44764466 | ||
Crocin prevents the death of rat pheochromyctoma (PC-12) cells by its antioxidant effects stronger than those of alpha-tocopherol | Q44899300 | ||
Haloperidol- and clozapine-induced oxidative stress in the rat brain | Q45011874 | ||
Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver | Q45053341 | ||
Paraquat induces apoptosis in human lymphocytes: protective and rescue effects of glucose, cannabinoids and insulin-like growth factor-1. | Q45154198 | ||
Acute reserpine and subchronic haloperidol treatments change synaptosomal brain glutamate uptake and elicit orofacial dyskinesia in rats. | Q45223107 | ||
Cholinergic stimulation of the ventrolateral striatum elicits mouth movements in rats: pharmacological and regional specificity | Q45270665 | ||
Effect of alpha lipoic acid on the tardive dyskinesia and oxidative stress induced by haloperidol in rats. | Q46011074 | ||
Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice | Q46163787 | ||
Effect of safranal on extracellular hippocampal levels of glutamate and aspartate during kainic Acid treatment in anesthetized rats | Q46347706 | ||
Effects of the active constituents of Crocus sativus L., crocins, in an animal model of anxiety | Q46436026 | ||
Ebselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain | Q46544075 | ||
New insights into the biological properties of Crocus sativus L.: chemical modifications, human monoamine oxidases inhibition and molecular modeling studies | Q46612378 | ||
Protective effects of saffron (its active constituent, crocin) on nephropathy in streptozotocin-induced diabetic rats | Q46880212 | ||
Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain | Q46893730 | ||
Nitric oxide, superoxide, and hydrogen peroxide production in brain mitochondria after haloperidol treatment | Q48139533 | ||
Behavioural effects of chronic haloperidol and risperidone treatment in rats | Q48447238 | ||
Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia | Q48854637 | ||
Resveratrol protects against a model of vacuous chewing movements induced by reserpine in mice | Q50122592 | ||
Protective effects of saffron extract and its active constituent crocin against oxidative stress and spatial learning and memory deficits induced by chronic stress in rats. | Q51007145 | ||
Tardive Dyskinesia | Q55894953 | ||
More Activated Cardiac Mitochondrial-dependent Apoptotic Pathway in Obese Zucker Rats** | Q60686154 | ||
Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia | Q69330809 | ||
Haloperidol-induced neurotoxicity--possible implications for tardive dyskinesia | Q73533445 | ||
Mechanism of hypolipidemic effect of crocin in rats: crocin inhibits pancreatic lipase | Q79861789 | ||
Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes | Q81294718 | ||
Saffron (Crocus sativus) aqueous extract and its constituent crocin reduces stress-induced anorexia in mice | Q83902348 | ||
Neuroprotective effect of crocin on acrylamide-induced cytotoxicity in PC12 cells | Q84912795 | ||
Saffron pre-treatment offers neuroprotection to Nigral and retinal dopaminergic cells of MPTP-Treated mice | Q87241775 | ||
P433 | issue | 10 | |
P921 | main subject | dyskinesia | Q629444 |
P304 | page(s) | 1070-1079 | |
P577 | publication date | 2016-10-01 | |
P1433 | published in | Iranian Journal of Basic Medical Sciences | Q20850646 |
P1476 | title | Crocin prevents haloperidol-induced orofacial dyskinesia: possible an antioxidant mechanism | |
P478 | volume | 19 |